La cadena de opciones muestra datos clave de las opciones de acciones de Surf Air Mobility a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Surf Air Mobility..

Surf Air Mobility (NYSE:SRFM) Bolsa, Cadena de Opciones

Surf Air Mobility

Surf Air Mobility Inc. Common Stock

Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.

Equities

News

Markets

Movers

General

PLTR

Roundhill ETF Trust Roundhill PLTR WeeklyPay ETF

PLTW

SCGLY

SRFM

Palantir expande su tecnología en banca y aviación, pero sus acciones caen. ¿Qué impacto tendrá esto en el mercado?

¿Qué está pasando con las acciones de Palantir (PLTR) el martes?

Surf Air Mobility Inc

Barclays analyst Benjamin Theurer downgrades BRF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRFS#NYSE">BRFS</a>) from Overweight to Equal-Weight and lowers the price target from $5 to $3.5.

Downgrades

Price Target

Analyst Ratings

BRFS

Barclays Downgrades BRF to Equal-Weight, Lowers Price Target to $3.5

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Gain Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GANX#NASDAQ">GANX</a>) with a Buy and maintains $8 price target.

Reiteration

GANX

HC Wainwright & Co. Reiterates Buy on Gain Therapeutics, Maintains $8 Price Target

Macro Economic Events

Economics

Federal Reserve

Fed's Bostic Says Moody's Downgrade Will Have Implications For Cost Of Capital, Could Ripple Through Economy; Also Says It Is Unclear If Consumers Can Take On Full Cost Of Tariffs Given State Of Household Balance Sheets And Recent Inflation

JP Morgan analyst Doug Anmuth downgrades Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) from Overweight to Neutral and raises the price target from $1150 to $1220.

NFLX

JP Morgan Downgrades Netflix to Neutral, Raises Price Target to $1220

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.fluor.com%2F&amp;esheet=54256315&amp;newsitemid=20250519864245&amp;lan=en-US&amp;anchor=Fluor+Corporation&amp;index=1&amp;md5=e7e9a1d9adb37b80a5108bff2f79f317">Fluor Corporation</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) announced today that Bayer's Cell Therapy Launch Facility in Berkeley, California, has been designated the first industrial manufacturing facility in the Western United States to achieve Leadership in Energy and Environmental Design (LEED) v4 Platinum Certification. The project was also named the 2025 Facility of the Year for Social Impact - Unmet Medical Needs by the International Society for Pharmaceutical Engineering (ISPE).
&nbsp;
Bayer's Cell Therapy Launch Facility in Berkeley, California.
LEED v4 Platinum certification is the highest level of recognition for sustainable building practices and indicates that a building meets the highest standards for sustainability.
Fluor's scope of work included the engineering, procurement, construction management, commissioning, qualification and validation for the 144,000-square-foot, state-of-the-art facility. It features 30,000 square feet of cleanroom space dedicated to advancing cell therapy production for neurological degenerative disorders, cardiovascular disease and other unmet medical needs.
"Fluor and Bayer collaborated to deliver Bayer's first fully electric pharmaceutical manufacturing plant, and we met an aggressive schedule to support client and patient needs," said Richard Meserole, President of Fluor's Advanced Technologies &amp; Life Sciences business. "Fluor secured LEED v4 Platinum Certification and ISPE Facility of the Year designation through effective collaboration with our trade partners, lean construction methods, and dedication to quality."
Sustainability benefits for the facility include 52.6% energy cost savings via LED, high-efficiency lighting, heat pump and rooftop solar installation. The facility boasts 100% process water reduction, 98% onsite management of rainfall high efficiency plumbing fixtures, 65% recycled content installation, high use of sustainable materials, land use maximization and various innovation credits.
This is the second new facility built by Fluor on Bayer's Biotech campus in Berkeley. Previously, Fluor completed construction of Bayer's state-of-the-art Single Use Technology biopharmaceutical manufacturing Cell Culture Technology Center in 2021.

Fluor-Built Bayer Facility Becomes First in Western US to Earn LEED v4 Platinum for Sustainability

Fomento Económico Mexicano, S.A.B. de C.V. ("FEMSA" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMX#NYSE">FMX</a>, BMV:<a class="ticker" href="https://www.benzinga.com/stock/FEMSAUBD#BMV">FEMSAUBD</a>, FEMSAUB))) today announced that, as part of its ongoing efforts and consistent with its capital allocation framework and commitment to enhance capital returns to shareholders, it has entered into a derivative instrument known as an accelerated share repurchase ("ASR") agreement with a financial institution in the United States of America to repurchase Company's shares through the acquisition of American Depositary Shares ("ADS"). Under the terms of the ASR agreement, FEMSA has agreed to repurchase from such financial institution an aggregate amount of USD $250 million of its ADS1. The ASR contemplates an initial delivery of 483,559 ADSs on May 20, 2025.
The total number of shares ultimately repurchased under the ASR agreement will be based on the daily volume-weighted average price of the Company's ADS during the term of the agreement, less a discount. The final settlement of the ASR agreement is expected to be completed, at the latest, in the third quarter of 2025.

Buybacks

BMV:FEMSAUBD

Fomento Economico Mexicano S.A.B. De C.V.

FEMSA Announces $250M Accelerated Share Repurchase Agreement, Initial Delivery Of 483,559 ADSs Scheduled For May 20, 2025

HC Wainwright &amp; Co. analyst Joseph Pantginis assumes Curis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRIS#NASDAQ">CRIS</a>) with a Buy rating and announces Price Target of $17.

Initiation

CRIS

HC Wainwright & Co. Assumes Curis at Buy, Announces Price Target of $17

Following Bitcoin&#8217;s highest weekly close ever, the crypto market may now face a wave of profit-taking and macro uncertainty, leaving observers caught in two minds about its next move.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$103,041.04</td>
<td>-0.8%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$2,416.42</td>
<td>-3.5</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$161.86</td>
<td>-5.4%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.32</td>
<td>-2.9%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.2177</td>
<td>-2%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001409</td>
<td>-4.1%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul class="wp-block-list">
<li>IntoTheBlock data shows Bitcoin large transaction volume decreased by 8.6% while Ethereum dropped by 16.7% in a single day. Ethereum exchanges netflows are up by 157%.</li>
<li>Coinglass data shows 154,467 traders were liquidated in the past 24 hours for $667.09 million.</li>
<li>SoSoValue data shows a net inflow of $260.3 million into spot Bitcoin ETFs on May 16. Spot Ethereum ETFs saw a net inflow of $22.1 million.</li>
</ul>
Trader Notes: Crypto trader Bleeker noted that despite recent volatility, "nothing meaningful has changed in over a month."
 Referencing a chart where $106,000 was pre-marked as resistance, he emphasized that altcoins won&#8217;t make any real move until Bitcoin hits a new all-time high. 
For now, BTC remains range-bound between $99,000 and $106,000, and Bleeker advises traders to "chill out — it's all part of the game.".
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">more crying in the casino nothing ever happens chart below is from over a month ago. red line at the $106k area was there in advance, resistance… resisted? alts aren't going to cook until btc goes on an ath run 99k &#8211; 106k the current playground. chill out. <a href="https://t.co/cpkXiKCO44">https://t.co/cpkXiKCO44</a> <a href="https://t.co/CHsPtJZhFV">pic.twitter.com/CHsPtJZhFV</a>
&mdash; bleeker (@__bleeker) <a href="https://twitter.com/__bleeker/status/1924365168282067233?ref_src=twsrc%5Etfw">May 19, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
In contrast, trader DonAlt <a href="https://x.com/CryptoDonAlt/status/1924371520815501340">pointed</a> out that Bitcoin has already closed at a new all-time high, breaking through all major resistances.
With BTC now in price discovery, he noted that while technically the "sky&#8217;s the limit," the rally's sustainability hinges on macro tailwinds: healthy institutional support, regulatory clarity, and Michael Saylor's MicroStrategy not buckling under market pressure.
While whales are <a href="https://x.com/lookonchain/status/1924279695019041080">accumulating</a> profits on Ethereum after the significant rally, analyst Michael van de Poppe <a href="https://x.com/CryptoMichNL/status/1924386796521026020">sees</a> $2,400 as a prime accumulation zone, suggesting a "buy the dip" setup ahead of an expected move toward $4,000.
As for XRP, crypto analyst Ali Martinez warned that a break below $2.30 could open the door for a drop back to $2.00. His technical outlook highlights the importance of maintaining this support level for bullish continuation.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24XRP&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$XRP</a> could return to $2 if it loses the critical $2.30 support! <a href="https://t.co/s6ozUyGYRC">pic.twitter.com/s6ozUyGYRC</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1924230013513040015?ref_src=twsrc%5Etfw">May 18, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Trader Tardigrade <a href="https://x.com/TATrader_Alan/status/1924389077174161603">observed</a> Dogecoin returning to its flag zone after testing the upper resistance of the pattern. 
He maintains that the bull flag structure remains intact, which typically signals continuation, if support holds.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45486536/tom-lee-says-bitcoin-is-the-way-after-strike-ceo-predicts-its-about-to-go-nuclear">Tom Lee Says &#8216;Bitcoin Is the Way&#8217; After Strike CEO Predicts It&#8217;s About To &#8216;Go Nuclear&#8217;</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$ETH

$SHIB

$SOL

$XRP

Bitcoin, Ethereum, XRP, Dogecoin Slide After Record Weekly BTC Close

JP Morgan analyst Puneet Jain downgrades Endava (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAVA#NYSE">DAVA</a>) from Overweight to Neutral and announces $18 price target.

DAVA

JP Morgan Downgrades Endava to Neutral, Announces $18 Price Target

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4430381-1&amp;h=3504812573&amp;u=http%3A%2F%2Fwww.extraspace.com%2F&amp;a=Extra+Space+Storage">Extra Space Storage</a> Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXR#NYSE">EXR</a>) (the "Company") announced today the planned succession for its Executive Vice President and Chief Financial Officer, P. Scott Stubbs, who will retire on December 31, 2025.&nbsp; Mr. Stubbs has spent 25 years in various roles with Extra Space Storage, most recently as the Chief Financial Officer since 2011.&nbsp; Mr. Stubbs has been instrumental in the Company's success over the past decades as an integral member of the management team that has grown the company from fewer than 100 stores to more than 4,000 locations today.&nbsp;

Management

Extra Space Storage CFO Scott Stubbs To Retire; To Be Succeeded By Jeff Norman, Effective July 1, 2025

BCLI: 120% &#x7C; <a href="https://www.benzinga.com//node/45489890">BrainStorm Cell Therapeutics shares are trading higher after the company received FDA clearance to initiate its Phase 3b trial of NurOwn for the treatment of ALS.</a>
&nbsp;
NVAX: 28% &#x7C; <a href="https://www.benzinga.com//node/45488265">Novavax Wins Limited FDA Nod For COVID Shot—Cleared Only For Seniors, High-Risk Groups Amid Safety Scrutiny</a>
&nbsp;
SOC: 18% &#x7C; <a href="https://www.benzinga.com//node/45489188">Sable Offshore Ramps Up Oil Production, Raises 2H25 Output Guidance to 40K–50K BOE/Day</a>

Trading Ideas

BCLI

NVAX

Market-Moving News for May 19th

U.S. stocks settled higher on Friday, with the S&amp;P 500 recording gains for the fifth straight session and also notching weekly gains.
For the week, the S&amp;P 500 gained 5.3%, while the Dow added 3.4%. The Nasdaq Composite was the standout performer, surging 7.2% last week.
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst&#8217;s opinion to trust.
Benzinga&#8217;s Analyst Ratings API is a collection of the highest-quality stock ratings curated by the Benzinga news desk via direct partnerships with major sell-side banks. Benzinga displays overnight ratings changes on a daily basis three hours prior to the U.S. equity market opening. Data specialists at investment dashboard provider Toggle.ai recently uncovered that the analyst insights Benzinga Pro subscribers and Benzinga readers regularly receive can successfully be used as trading indicators to outperform the stock market.
Top Analyst Picks: Fortunately, any Benzinga reader can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. One of the ways traders can sort through Benzinga&#8217;s extensive database of analyst ratings is by analyst accuracy. Here&#8217;s a look at the most recent stock picks from each of the five most accurate Wall Street analysts, according to Benzinga <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock</a> Ratings.
Analyst: Leo Mariani
<ul class="wp-block-list">
<li>Analyst Firm: Roth Capital</li>
<li>Ratings Accuracy: 88%</li>
<li>Latest Rating: Downgraded rating on Murphy Oil Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUR#NYSE">MUR</a>) from Buy to Neutral and cut the price target from $27 to $25 on May 15. This analyst sees around 12% upside in the stock.</li>
<li>Recent News: On May 7, Murphy Oil posted better-than-expected quarterly earnings.</li>
</ul>
Analyst: Jay McCanless
<ul class="wp-block-list">
<li>Analyst Firm: Wedbush</li>
<li>Ratings Accuracy: 87%</li>
<li>Latest Rating: Reiterated an Outperform rating on Toll Brothers, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>) with a price target of $175 on May 15. This analyst sees around 66% surge in the stock.</li>
<li>Recent News: Toll Brothers will announce its second quarter FY 2025 results after the market close on Tuesday, May 20.</li>
</ul>
Analyst: Josh Sullivan 
<ul class="wp-block-list">
<li>Analyst Firm: Benchmark</li>
<li>Ratings Accuracy: 86%</li>
<li>Latest Rating: Maintained a Buy rating on BlackSky Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKSY#NASDAQ">BKSY</a>) and increased the price target from $17 to $18 on May 13. This analyst sees around 49% upside in the stock.</li>
<li>Recent News: On May 8, BlackSky Technology reported better-than-expected first-quarter EPS results.</li>
</ul>
Analyst: Alexander Paris
<ul class="wp-block-list">
<li>Analyst Firm: Barrington Research</li>
<li>Ratings Accuracy: 86%</li>
<li>Latest Rating: Maintained an Outperform rating on zSpace, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZSPC#NASDAQ">ZSPC</a>) and cut the price target from $11 to $10 on May 15. This analyst sees around 46% upside in the stock.</li>
<li>Recent News: On May 14, ZSPACE posted mixed quarterly results.</li>
</ul>
Analyst: Andres Sheppard
<ul class="wp-block-list">
<li>Analyst Firm: Cantor Fitzgerald</li>
<li>Ratings Accuracy: 85%</li>
<li>Latest Rating: Maintained an Overweight rating on Intuitive Machines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) and boosted the price target from $13 to $16 on May 14. This analyst sees around 34% upside in the stock.</li>
<li>Recent News: On May 13, Intuitive Machines reported first-quarter revenue of $62.5 million, up 14% on a quarter-over-quarter basis.</li>
</ul>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/05/45466849/top-3-consumer-stocks-that-may-fall-off-a-cliff-in-q2">Top 3 Consumer Stocks That May Fall Off A Cliff In Q2</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

BlackSky Technology Inc. Class A Common Stock

BKSY

LUNR

ZSPC

5 Stock Picks Last Week From Wall Street's Most Accurate Analysts

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Benitec Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTC#NASDAQ">BNTC</a>) with a Buy and maintains $28 price target.

BNTC

HC Wainwright & Co. Reiterates Buy on Benitec Biopharma, Maintains $28 Price Target

Continued momentum in sales to Tier-1 defense manufacturers gearing up for program of record deliveries for end users including the U.S. Department of Defense (DoD) and other major world militaries
Mobilicom's systems added to the DoD's Blue UAS Framework marks a major catalyst
Strong cash position of ~$8 million with narrowing burn rate provides runway to execute on large market opportunities

Mobilicom Delivers Q1 With $844K Revenue, $8M Cash, And Expanding Pipeline of Defense And Robotics Orders

JP Morgan analyst Puneet Jain upgrades CI&amp;T (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CINT#NYSE">CINT</a>) from Neutral to Overweight and announces $7 price target.

Upgrades

CINT

JP Morgan Upgrades CI&T to Overweight, Announces $7 Price Target

Iterum Therapeutics plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRM#NASDAQ">ITRM</a>) (the "Company" or "Iterum"), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today reported that Pfizer Inc. ("Pfizer") has agreed to extend the term for payment of the regulatory milestone payment of $20.0 million until October 25, 2029.
"We are very pleased to announce that Pfizer has agreed to extend the due date for payment of the regulatory milestone associated with ORLYNVAH&#x2122;'s approval by the FDA," said Corey Fishman, Iterum's Chief Executive Officer. "The $20.0 million promissory note was due October 2026 and is now due October 2029. As a result, any capital raised or earned in the near term from the sales of ORLYNVAH&#x2122;&nbsp;can be strategically invested to enable a successful launch of ORLYNVAH&#x2122;, including through the expansion into new territories or concentration of resources in high prescribing geographies."
Pursuant to the license agreement entered into on November 18, 2015, by and among the Company, Iterum Therapeutics International Limited ("ITIL") and Pfizer (the "Pfizer License Agreement"), ITIL agreed to make a regulatory milestone payment of $20.0 million to Pfizer (the "Milestone Payment") upon the approval of oral sulopenem for commercial sale in the United States by the U.S. Food and Drug Administration ("FDA"). The Company had the option to deliver notice of its election to defer such payment for up to two years from the date of approval and have a promissory note issued by ITIL in the amount of the Milestone Payment to Pfizer. After receiving FDA approval for ORLYNVAH&#x2122; on October, 25, 2024, the Company notified Pfizer on October 28, 2024, that it was electing to defer payment of the Milestone Payment for two years, or until October 25, 2026 (the "Deferral Period"), and a promissory note was issued to Pfizer by ITIL.

ITRM

Iterum Gets Pfizer to Extend $20M Milestone Payment for ORLYNVAH Approval to 2029

JP Morgan analyst Tien-Tsin Huang upgrades Marqeta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MQ#NASDAQ">MQ</a>) from Neutral to Overweight and raises the price target from $5 to $6.

JP Morgan Upgrades Marqeta to Overweight, Raises Price Target to $6

LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.15) by 33.33 percent. This is a 23.08 percent increase over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $9.48 million. This is a 7.43 percent decrease over sales of $10.24 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

LNZA

LanzaTech Global Q1 EPS $(0.10) Beats $(0.15) Estimate, Sales $9.48M

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates aTyr Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATYR#NASDAQ">ATYR</a>) with a Buy and maintains $35 price target.

ATYR

HC Wainwright & Co. Reiterates Buy on aTyr Pharma, Maintains $35 Price Target

CoreWeave intends to use the proceeds from the offering of the Notes for general corporate purposes, including, without limitation, repayment of outstanding indebtedness, and to pay fees, costs and expenses in connection with the offering of the Notes.

CRWV

CoreWeave To Offer $1.5B In Senior Notes Due 2030 In Private Placement

Press Releases

Surf Air Mobility Relocates Air Operations Center to Addison, TX

Surf Air Mobility Strengthens Aviation Leadership Team with Key Executive Appointments

Surf Air Mobility Announces Launch Customers for SurfOS™ Software

Surf Air Mobility to Announce Fourth Quarter and Year End 2024 Financial Results on March 18, 2025

Surf Air Mobility Reports Fourth Quarter and Full Year 2024 Financial Results

Surf Air Mobility Announces $5 Million Registered Direct Offering of Common Stock

Surf Air Mobility Closes $5 Million Registered Direct Offering of Common Stock

Surf Air Mobility to Announce First Quarter 2025 Financial Results on May 13, 2025

Mokulele Airlines and Japan Airlines Announce New Interline Agreement

Surf Air Mobility to Present at the Third Annual Jefferies eVTOL / AAM Summit

American Airlines Group, Inc. - Common Stock

American Airlines Group

Allegiant Travel

Alaska Air Gr

Azul S.A. American Depositary Shares (each representing three preferred shares)

Azul

Blade Air Mobility, Inc. - Class A Common Stock

Blade Air Mobility

Copa Holdings

Delta Air Lines

flyExclusive

JetBlue Airways Corporation - Common Stock

JetBlue Airways

Joby Aviation

Jet AI

LATAM Airlines Group S.A. American Depositary Shares (each representing two thousand (2,000) shares of Common Stock)

LATAM Airlines Group

Southwest Airlines

Mesa Air Gr

Ryanair Holdings plc - American Depositary Shares, each representing five Ordinary Shares

Ryanair Hldgs

SkyWest

Sun Country Airlines Holdings, Inc. - Common Stock

Sun Country Airlines

Volato Group

United Airlines Holdings, Inc. - Common Stock

United Airlines Holdings

Frontier Group Holdings, Inc. - Common Stock

Frontier Group Holdings

Wheels Up Experience Inc. Class A Common Stock

Wheels Up Experience

Controladora Vuela Compania de Aviacion, S.A.B. de C.V. American Depositary Shares, each representing ten (10) Ordinary Participation Certificates

Comments

Surf Air Mobility

Surf Air Mobility (SRFM) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL